Add time:08/26/2019         Source:sciencedirect.com

We describe herein a new and straightforward enantioselective approach to R-(+)-2-ethyl-2,3-dihydrofuran carboxylic acid, the direct precursor of (+)-efaroxan, an α2 adrenoreceptor antagonist, which is indicated to be used for the treatment of neurodegenerative diseases (Alzheimer and Parkinson), migraine and type II diabetes. Our goal was accomplished using a Baylis–Hillman adduct as starting material. The dihydrobenzofuran acid was obtained in eight steps with an overall yield of 14%.

We also recommend Trading Suppliers and Manufacturers of 2-Ethyl-2,3-dihydrobenzofuran-2-carboxylic acid (cas 111080-50-3). Pls Click Website Link as below: cas 111080-50-3 suppliers